Skip to content

Evaluation of Sound Processor for a Transcutaneous System

Single Center Evaluation of a Sound Processor for a Transcutaneous System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03374787
Enrollment
10
Registered
2017-12-15
Start date
2017-11-15
Completion date
2018-11-22
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive Hearing Loss, Mixed Hearing Loss

Brief summary

A single center study evaluating the performance of an externally worn sound processor for a transcutaneous bone anchored hearing system using audiological outcomes measures such as aided thresholds and speech intelligibility and self evaluation questionnaires.

Detailed description

Bone conduction hearing systems use the body's natural ability to transfer sound through bone conduction. The sound processor picks up sound and converts it into vibrations that are transferred through the skull bone to the inner ear (cochlea). Thus, for patients with conductive or mixed hearing losses, patients with lasting hearing loss following a middle ear disease or malformations (such as microtia), the vibrations are bypassing the conductive problem in the ear canal or middle ear. Bone conduction devices currently on the market are divided into three types; transcutaneous direct drive, percutaneous (skin penetrating) direct drive and transcutaneous skin drive bone conduction devices. This evaluation focus on a sound processor used for a transcutaneous system.

Interventions

DEVICEFusion Sound Processor

Sound Processor

Sponsors

Sahlgrenska University Hospital
CollaboratorOTHER
Oticon Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subjects implanted with the Bridging Bone Conductor (BBC) implant * Subjects that have completed one year follow up in Osseofon BCI (Bone Conduction Implant) study * Subjects available for 6 months study procedures without affecting the follow ups in the Osseofon BCI study * Active user of the BCI SP

Exclusion criteria

* Inability to participate in follow-ups * Unsuitable as judged by the principle investigator or the sub-investigator

Design outcomes

Primary

MeasureTime frameDescription
Aided Thresholds Fusion-unaided PTA6 monthsDifference between Fusion-aided and unaided sound field Pure Tone Average of thresholds of frequencies 500, 1000, 2000 and 4000 Hz (PTA 4)

Secondary

MeasureTime frameDescription
Aided Thresholds Fusion PTA4Baseline, 1 and 6 month(s)Difference between Fusion-aided sound field PTA4, the average for frequencies 500, 1000, 2000 and 4000 Hz (PTA 4)
Aided Thresholds FusionBaseline, 1 and 6 month(s)Difference between Fusion-aided sound field pure tones at frequencies 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz at
Aided Thresholds Fusion-BCI PTA46 monthsDifference between Fusion-aided and BCI-aided sound field Pure Tone Average 4 at frequencies 500, 1000, 2000 and 4000 Hz (PTA4)
Aided Thresholds Fusion-BCI6 monthsDifference between Fusion-aided and BCI-aided sound field pure tones at frequencies 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz
Speech Intelligibility Fusion-unaided %6 monthsDifference between Fusion-aided and unaided speech intelligibility scores (in % correct). Score indicates number of word repeated correctly with aided with the Fusion sound processor compared to unaided. Ranges from 0-100, a higher score indicates better performance. No scale is used.
Speech Intelligibility Fusion-unaided Signal to Noise Ratio (SNR)6 monthsDifference between Fusion-aided and unaided sound field speech intelligibility scores in SNR. Score indicates the signal to noise ratio where the subject can repeat 50% of the words correct. A lower score means a better outcome. No scale is used.
Speech Intelligibility Fusion %Baseline, 1 and 6 month(s)Difference between Fusion-aided speech intelligibility scores (in % correct). Score indicates number of word repeated correctly with aided with the Fusion sound processor compared to unaided. Ranges from 0-100, a higher score indicates better performance. No scale is used.
Aided Thresholds Fusion-unaided6 monthsDifference between Fusion-aided and unaided sound field Pure Tone thresholds at frequencies 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz
Speech Intelligibility Fusion-BCI %6 monthsDifference between Fusion-aided BCI-aided speech intelligibility scores (in % correct). Score indicates number of word repeated correctly with aided with the Fusion sound processor compared to unaided. Ranges from 0-100, a higher score indicates better performance. No scale is used
Speech Intelligibility Fusion-BCI SNR6 monthsDifference between Fusion-aided and BCI-aided sound field speech intelligibility scores in SNR. Score indicates the signal to noise ratio where the subject can repeat 50% of the words correct. A lower score means a better outcome. No scale is used.
Magnet StrengthBaseline, 1 and 6 month(s)Difference in magnet strength measured on the patient's heads in Newton
IPS (Inflammation, Pain, Skin Height/Numbness) EvaluationBaseline, 1 and 6 month(s)Combined score of IInflammation, Pain and Skin height/numbness scale evaluating the skin area under the sound processor. I scale ranging from 0-4, Pain scale ranging from 0-2, Skin height/numbness ranging from 0-2. Total score 0-8 (0 no adverse skin condition, 8 maximum adverse skin reactions on all subscales). Lower score means better performance
Subjective EvaluationBaseline, 1 and 6 month(s)User satisfaction and usability as measured with questionniare Usage of sound processor consisting of rating scales on satisfaction of the sound processor. The scale used is a scale with descriptive values.
Subjective Evaluation SSQBaseline, 1 and 6 month(s)Subjective performance as measured by Speech, Spatial and Qualities of hearing (SSQ) a scale from 0-10 where 0 represents Not at all and 10 represents Perfect. A higher score means better performance.
Speech Intelligibility Fusion SNRBaseline, 1 and 6 month(s)Difference between Fusion-aided sound field sound field speech intelligibility scores in SNR. Score indicates the signal to noise ratio where the subject can repeat 50% of the words correct. A lower score means a better outcome. No scale is used.

Countries

Sweden

Participant flow

Participants by arm

ArmCount
Fusion Sound Processor
The group is fitted with a Fusion Sound Processor. The sound processor picks up the sound and transfer it to the implant that convert the sound to vibrations that are transmitted to the inner ear.
10
Total10

Baseline characteristics

CharacteristicFusion Sound Processor
Age, Continuous46.7 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Sweden
10 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
7 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Aided Thresholds Fusion-unaided PTA

Difference between Fusion-aided and unaided sound field Pure Tone Average of thresholds of frequencies 500, 1000, 2000 and 4000 Hz (PTA 4)

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
Fusion Sound ProcessorAided Thresholds Fusion-unaided PTA29.6 dBStandard Deviation 4.4
Secondary

Aided Thresholds Fusion

Difference between Fusion-aided sound field pure tones at frequencies 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz at

Time frame: Baseline, 1 and 6 month(s)

Secondary

Aided Thresholds Fusion-BCI

Difference between Fusion-aided and BCI-aided sound field pure tones at frequencies 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz

Time frame: 6 months

Secondary

Aided Thresholds Fusion-BCI PTA4

Difference between Fusion-aided and BCI-aided sound field Pure Tone Average 4 at frequencies 500, 1000, 2000 and 4000 Hz (PTA4)

Time frame: 6 months

Secondary

Aided Thresholds Fusion PTA4

Difference between Fusion-aided sound field PTA4, the average for frequencies 500, 1000, 2000 and 4000 Hz (PTA 4)

Time frame: Baseline, 1 and 6 month(s)

ArmMeasureGroupValue (MEAN)Dispersion
Fusion Sound ProcessorAided Thresholds Fusion PTA4Difference between 0-1 months-0.290 dBStandard Deviation 1.386
Fusion Sound ProcessorAided Thresholds Fusion PTA4Difference between 0-6 months-1.07 dBStandard Deviation 2.93
Fusion Sound ProcessorAided Thresholds Fusion PTA4Difference between 1-6 months-0.78 dBStandard Deviation 2.754
Secondary

Aided Thresholds Fusion-unaided

Difference between Fusion-aided and unaided sound field Pure Tone thresholds at frequencies 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz

Time frame: 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Fusion Sound ProcessorAided Thresholds Fusion-unaided800017.5 dBStandard Deviation 10.1
Fusion Sound ProcessorAided Thresholds Fusion-unaided200027.5 dBStandard Deviation 8.2
Fusion Sound ProcessorAided Thresholds Fusion-unaided300025.0 dBStandard Deviation 8.2
Fusion Sound ProcessorAided Thresholds Fusion-unaided400026.5 dBStandard Deviation 7.8
Fusion Sound ProcessorAided Thresholds Fusion-unaided600022.5 dBStandard Deviation 8.6
Fusion Sound ProcessorAided Thresholds Fusion-unaided25010.05 dBStandard Deviation 5.5
Fusion Sound ProcessorAided Thresholds Fusion-unaided50026.5 dBStandard Deviation 7.5
Fusion Sound ProcessorAided Thresholds Fusion-unaided75036.5 dBStandard Deviation 5.3
Fusion Sound ProcessorAided Thresholds Fusion-unaided100038.0 dBStandard Deviation 7.9
Fusion Sound ProcessorAided Thresholds Fusion-unaided150028.5 dBStandard Deviation 6.7
Secondary

IPS (Inflammation, Pain, Skin Height/Numbness) Evaluation

Combined score of IInflammation, Pain and Skin height/numbness scale evaluating the skin area under the sound processor. I scale ranging from 0-4, Pain scale ranging from 0-2, Skin height/numbness ranging from 0-2. Total score 0-8 (0 no adverse skin condition, 8 maximum adverse skin reactions on all subscales). Lower score means better performance

Time frame: Baseline, 1 and 6 month(s)

Secondary

Magnet Strength

Difference in magnet strength measured on the patient's heads in Newton

Time frame: Baseline, 1 and 6 month(s)

Secondary

Speech Intelligibility Fusion %

Difference between Fusion-aided speech intelligibility scores (in % correct). Score indicates number of word repeated correctly with aided with the Fusion sound processor compared to unaided. Ranges from 0-100, a higher score indicates better performance. No scale is used.

Time frame: Baseline, 1 and 6 month(s)

Secondary

Speech Intelligibility Fusion-BCI %

Difference between Fusion-aided BCI-aided speech intelligibility scores (in % correct). Score indicates number of word repeated correctly with aided with the Fusion sound processor compared to unaided. Ranges from 0-100, a higher score indicates better performance. No scale is used

Time frame: 6 months

Secondary

Speech Intelligibility Fusion-BCI SNR

Difference between Fusion-aided and BCI-aided sound field speech intelligibility scores in SNR. Score indicates the signal to noise ratio where the subject can repeat 50% of the words correct. A lower score means a better outcome. No scale is used.

Time frame: 6 months

Secondary

Speech Intelligibility Fusion SNR

Difference between Fusion-aided sound field sound field speech intelligibility scores in SNR. Score indicates the signal to noise ratio where the subject can repeat 50% of the words correct. A lower score means a better outcome. No scale is used.

Time frame: Baseline, 1 and 6 month(s)

Secondary

Speech Intelligibility Fusion-unaided %

Difference between Fusion-aided and unaided speech intelligibility scores (in % correct). Score indicates number of word repeated correctly with aided with the Fusion sound processor compared to unaided. Ranges from 0-100, a higher score indicates better performance. No scale is used.

Time frame: 6 months

Secondary

Speech Intelligibility Fusion-unaided Signal to Noise Ratio (SNR)

Difference between Fusion-aided and unaided sound field speech intelligibility scores in SNR. Score indicates the signal to noise ratio where the subject can repeat 50% of the words correct. A lower score means a better outcome. No scale is used.

Time frame: 6 months

Secondary

Subjective Evaluation

User satisfaction and usability as measured with questionniare Usage of sound processor consisting of rating scales on satisfaction of the sound processor. The scale used is a scale with descriptive values.

Time frame: Baseline, 1 and 6 month(s)

Secondary

Subjective Evaluation SSQ

Subjective performance as measured by Speech, Spatial and Qualities of hearing (SSQ) a scale from 0-10 where 0 represents Not at all and 10 represents Perfect. A higher score means better performance.

Time frame: Baseline, 1 and 6 month(s)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026